Skip to content

Evaluation of the Utility of Urinary PGE-MUM in Inflammatory Bowel Disease: A Multicenter Prospective Study

Evaluation of the Utility of Urinary PGE-MUM in Inflammatory Bowel Disease: A Multicenter Prospective Study - Evaluation of the Utility of Urinary PGE-MUM in Inflammatory Bowel Disease: A Multicenter Prospective Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000061836
Enrollment
180
Registered
2026-06-15
Start date
2025-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis, Crohn&#39

Interventions

None listed

Sponsors

Okayama University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with inflammatory bowel disease who are receiving outpatient or inpatient care at Okayama University Hospital or participating research institutions

Exclusion criteria

Exclusion criteria: 1.Patients without a confirmed diagnosis 2.Patients with ulcerative colitis who have undergone total colectomy 3.Patients with active malignancy 4.Pregnant or breastfeeding patients 5.Patients who have not provided consent to participate in this study 6.Patients deemed unsuitable for participation by the principal investigator

Design outcomes

Primary

MeasureTime frame
prediction of clinical outcomes, including treatment response

Countries

Japan

Contacts

Public ContactYuki Aoyama

Okayama University Hospital Department of Gastroenterology and Hepatology

yublue.med@gmail.com0862357219

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026